Huapont Life Sciences Co., Ltd.

SZSE:002004.SZ

4.76 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001
Revenue 11,594.5913,232.36612,359.18310,876.36210,091.3710,573.6289,108.97,092.786,174.3064,866.6894,463.6313,877.393638.098541.224544.521575.72492.372285.227273.505272.532240.443200.224174.054
Cost of Revenue 7,059.5247,874.0687,605.5586,421.3145,395.7966,281.6636,195.0714,752.6114,040.4043,383.4513,297.0612,892.849211.723176.882189.709203.165182.62763.66163.19764.56970.74263.98556.41
Gross Profit 4,535.0665,358.2984,753.6254,455.0484,695.5744,291.9642,913.832,340.1692,133.9021,483.2381,166.57984.544426.374364.342354.812372.555309.745221.566210.308207.963169.701136.238117.645
Gross Profit Ratio 0.3910.4050.3850.410.4650.4060.320.330.3460.3050.2610.2540.6680.6730.6520.6470.6290.7770.7690.7630.7060.680.676
Reseach & Development Expenses 419.139385.239329.471324.353288.027349.462210.624140.404131.32398.8573.62361.91312.34410.939004.28000000
General & Administrative Expenses 432.553540.625400.552403.093398.25362.682268.079227.665183.758139.534109.6198.52140.35339.05385.33486.96221.66945.99548.96140.41231.07919.29115.93
Selling & Marketing Expenses 1,303.3131,502.4481,615.6061,569.9151,774.9331,517.5991,090.596745.357659.826445.071339.345271.116207.424151.699159.211193.768157.211109.17697.715103.0185.66666.46962.807
SG&A 1,735.8662,043.0722,016.1571,973.0082,173.1831,880.2811,358.676973.021843.584584.605448.955369.636247.777190.751244.545280.73178.88155.171146.676143.422116.74585.7678.737
Other Expenses -34.124921.735784.379599.356646.418635.981417.96783.564-14.0596.06711.29824.68420.7768.9114.6653.5880.8560.7880.3010.0682.191-0.205-0.203
Operating Expenses 3,032.1723,350.0463,130.0082,896.7183,107.6282,865.7241,987.2661,501.1771,299.565918.118710.933585.533320.127256.06251.896288.626230.963159.546150.671149.005121.56389.58981.574
Operating Income 926.5112,653.8761,893.8991,740.2271,832.4371,772.6851,139.153657.789752.762481.417384.843425.874306.125149.858137.39899.594246.79570.03363.21358.92847.35944.18336.163
Operating Income Ratio 0.080.2010.1530.160.1820.1680.1250.0930.1220.0990.0860.110.480.2770.2520.1730.5010.2460.2310.2160.1970.2210.208
Total Other Income Expenses Net -34.124-1,031.18-607.896-575.144-683.09-698.582-457.381-138.683-77.024-68.099-64.96547.051219.59543.26744.47218.875167.2846.5482.484-0.377-3.159-2.953-0.113
Income Before Tax 892.3881,622.6961,286.0031,165.0831,149.3471,074.103681.772700.309757.313497.02390.672446.063325.842151.549147.388102.805246.06769.69462.81758.78947.26543.83735.959
Income Before Tax Ratio 0.0770.1230.1040.1070.1140.1020.0750.0990.1230.1020.0880.1150.5110.280.2710.1790.50.2440.230.2160.1970.2190.207
Income Tax Expense 215.456495.959361.042270.078217.444251.28688.10588.629100.48951.02173.68475.25417.40816.3718.14112.72423.44410.80410.92111.8867.77.0184.851
Net Income 302.1221,126.736924.961895.006931.903822.817507.906566.868636.625429.184302.449332.384305.279132.042127.68488.81206.45558.44652.49947.64839.92237.29531.108
Net Income Ratio 0.0260.0850.0750.0820.0920.0780.0560.080.1030.0880.0680.0860.4780.2440.2340.1540.4190.2050.1920.1750.1660.1860.179
EPS 0.150.570.470.450.470.410.250.280.340.270.210.260.310.130.130.0950.210.0650.0530.0360.040.0380.032
EPS Diluted 0.150.570.470.450.470.410.250.280.340.270.210.260.310.130.130.0950.210.0650.0530.0360.040.0380.032
EBITDA 2,480.453,454.1052,641.7782,436.542,439.5822,359.4391,526.3381,506.5311,437.9321,008.689625.61563.298371.544206.224160.102166.457289.55683.63575.4568.61956.60749.96636.331
EBITDA Ratio 0.2140.2610.2140.2240.2420.2230.1680.2120.2330.2070.140.1450.5820.3810.2940.2890.5880.2930.2760.2520.2350.250.209